Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00003591
Other study ID # RTOG-9812
Secondary ID CDR0000066661
Status Completed
Phase Phase 2
First received November 1, 1999
Last updated November 11, 2013
Start date November 1998
Est. completion date October 2005

Study information

Verified date November 2013
Source Radiation Therapy Oncology Group
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of radiation therapy plus paclitaxel in treating patients who have nonmetastatic, unresectable pancreatic cancer.


Description:

OBJECTIVES: I. Determine the response rate of patients with nonmetastatic, unresectable pancreatic cancer receiving external beam irradiation and weekly paclitaxel. II. Determine the median survival after this treatment in these patients. III. Evaluate the acute and late treatment morbidity of paclitaxel in these patients. IV. Correlate p53 status with treatment response to this treatment in this patient population.

OUTLINE: This is a open label, multicenter study. Patients are highly recommended to undergo laparoscopic surgical staging prior to protocol to exclude peritoneal and hepatic metastases. Patients receive paclitaxel IV over 3 hours weekly for 6 weeks beginning on day 1 followed 1.5 hours later by external beam radiotherapy daily 5 days a week for 5.5 weeks beginning on day 1. All patients are restaged with an abdominal CT scan 6 weeks following completion of chemoradiotherapy. If there is marked response to treatment at this time, curative surgery may be attempted at the discretion of the attending surgeon. Patients are followed every 3 months for 1 year, every 4 months for the second year, every 6 months for years 3-5, and annually thereafter.

PROJECTED ACCRUAL: A total of 100 patients will be accrued into this study over 12 months.


Recruitment information / eligibility

Status Completed
Enrollment 122
Est. completion date October 2005
Est. primary completion date June 2001
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility DISEASE CHARACTERISTICS: Histologically confirmed nonmetastatic, unresectable pancreatic adenocarcinoma No evidence of metastatic disease in the major viscera and no peritoneal seeding Residual disease after resection (R-1 or -2 micro- and macroscopic residual) eligible if measurable disease on the post operative CT or MRI scan Recurrent disease following radical surgery is eligible All malignant disease must be encompassable within a single irradiation field Must be a radiographically assessable disease CT with 5 mm cuts or spiral CT

PATIENT CHARACTERISTICS: Age: 18 and over Performance status: Karnofsky 60-100% Life expectancy: Not specified Hematopoietic: Granulocyte count at least 1,800/mm3 Platelet count at least 100,000/mm3 Hepatic: Bilirubin no greater than 2 mg/dL Biliary system stented Renal: Creatinine less than 3.0 mg/dL OR Creatinine clearance at least 40 mL/min Other: If patients have biliary or gastroduodenal obstruction, they must have drainage prior to starting chemoradiation Oral intake of at least 1,500 calories per day No significant infection or other coexistent medical condition

PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: No prior paclitaxel At least 4 weeks since prior gemcitabine No other prior chemotherapy Endocrine therapy: Not specified Radiotherapy: No prior radiotherapy to the planned field Surgery: See Disease Characteristics

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
paclitaxel

Radiation:
radiation therapy


Locations

Country Name City State
Canada Tom Baker Cancer Center - Calgary Calgary Alberta
Canada Cross Cancer Institute Edmonton Alberta
Canada Nova Scotia Cancer Centre Halifax Nova Scotia
Canada Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton Ontario
Canada Kingston Regional Cancer Centre Kingston Ontario
Canada Cancer Care Ontario-London Regional Cancer Centre London Ontario
Canada Doctor Leon Richard Oncology Centre Moncton New Brunswick
Canada Centre Hospitalier de l'Universite de Montreal Montreal Quebec
Canada McGill University Department of Oncology Montreal Quebec
Canada Ottawa Regional Cancer Centre - Civic Campus Ottawa Ontario
Canada Saint John Regional Hospital Saint John New Brunswick
Canada Saskatoon Cancer Centre Saskatoon Saskatchewan
Canada Northeastern Ontario Regional Cancer Centre, Sudbury Sudbury Ontario
Canada Northwestern Ontario Regional Cancer Centre, Thunder Bay Thunder Bay Ontario
Canada Princess Margaret Hospital Toronto Ontario
Canada British Columbia Cancer Agency - Vancouver Island Cancer Centre Victoria British Columbia
United States Akron City Hospital Akron Ohio
United States Akron General Medical Center Akron Ohio
United States Cancer Center of Albany Medical Center Albany New York
United States Veterans Affairs Medical Center - Albany Albany New York
United States Saint Joseph Medical Center Albuquerque New Mexico
United States Providence Cancer Therapy Center Anchorage Alaska
United States St. John's Medical Center Anderson Indiana
United States CCOP - Ann Arbor Regional Ann Arbor Michigan
United States University of Michigan Comprehensive Cancer Center Ann Arbor Michigan
United States Veterans Affairs Medical Center - Ann Arbor Ann Arbor Michigan
United States Anne Arundel Oncology Center Annapolis Maryland
United States CCOP - Atlanta Regional Atlanta Georgia
United States Emory University Hospital - Atlanta Atlanta Georgia
United States Greater Baltimore Medical Center and Cancer Center Baltimore Maryland
United States Harbor Hospital Center Baltimore Maryland
United States Johns Hopkins Oncology Center Baltimore Maryland
United States Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore Maryland
United States Radiation Oncology Affiliates of Maryland, P.A. Baltimore Maryland
United States Mary Bird Perkins Cancer Center Baton Rouge Louisiana
United States Julie and Ben Rogers Cancer Institute Beaumont Texas
United States CCOP - Southwestern Vermont Regional Cancer Center Bennington Vermont
United States CCOP - Montana Cancer Consortium Billings Montana
United States University of Alabama Comprehensive Cancer Center Birmingham Alabama
United States Veterans Affairs Medical Center - Birmingham Birmingham Alabama
United States Joint Center for Radiation Therapy Boston Massachusetts
United States Massachusetts General Hospital Cancer Center Boston Massachusetts
United States Medical Center at Bowling Green Bowling Green Kentucky
United States Bridgeport Hospital Bridgeport Connecticut
United States Albert Einstein Comprehensive Cancer Center Bronx New York
United States New York Methodist Hospital Brooklyn New York
United States State University of New York Health Science Center at Brooklyn Brooklyn New York
United States Providence Saint Joseph Medical Center - Burbank Burbank California
United States Lineberger Comprehensive Cancer Center, UNC Chapel Hill North Carolina
United States Medical University of South Carolina Charleston South Carolina
United States Cancer Center, University of Virginia HSC Charlottesville Virginia
United States Martha Jefferson Hospital Charlottesville Virginia
United States Northwestern Memorial Hospital Chicago Illinois
United States University of Chicago Cancer Research Center Chicago Illinois
United States Christ Hospital Cincinnati Ohio
United States Lykes Center for Radiation Therapy Clearwater Florida
United States Ireland Cancer Center Cleveland Ohio
United States Memorial Hospital Cancer Center Colorado Springs Colorado
United States Ellis Fischel Cancer Center - Columbia Columbia Missouri
United States Arthur G. James Cancer Hospital - Ohio State University Columbus Ohio
United States CCOP - Columbus Columbus Ohio
United States Mount Diablo Medical Center Concord California
United States Samaritan Regional Cancer Center Corvallis Oregon
United States Penn State Geisinger Medical Center Danville Pennsylvania
United States Mercy Catholic Medical Center, Mercy Fitzgerald Divison Darby Pennsylvania
United States Veterans Affairs Medical Center - Dayton Dayton Ohio
United States Halifax Medical Center Daytona Beach Florida
United States University of Colorado Cancer Center Denver Colorado
United States Barbara Ann Karmanos Cancer Institute Detroit Michigan
United States Henry Ford Hospital Detroit Michigan
United States Delaware County Memorial Hospital Drexel Hill Pennsylvania
United States Beckman Research Institute, City of Hope Duarte California
United States Wendt Regional Cancer Center of Finley Hospital Dubuque Iowa
United States Veterans Affairs Medical Center - East Orange East Orange New Jersey
United States John F. Kennedy Medical Center Edison New Jersey
United States Elizabeth General Medical Center - West Elizabeth New Jersey
United States Meritcare Roger Maris Cancer Center Fargo North Dakota
United States Hurley Medical Center Flint Michigan
United States Radiation Therapy Associates - Fort Myers Fort Myers Florida
United States California Cancer Center Fresno California
United States Saint Agnes Cancer Center Fresno California
United States University of Florida Health Science Center Gainesville Florida
United States University of Texas Medical Branch Galveston Texas
United States Glendale Memorial Hospital and Health Center Glendale California
United States St. Vincent Hospital Green Bay Wisconsin
United States Sutter Health Western Division Cancer Research Group Greenbrae California
United States CCOP - Greenville Greenville South Carolina
United States East Carolina University School of Medicine Greenville North Carolina
United States Ingalls Memorial Hospital Harvey Illinois
United States Penn State Geisinger Cancer Center Hershey Pennsylvania
United States University of Texas - MD Anderson Cancer Center Houston Texas
United States Huntsville Hospital System Huntsville Alabama
United States Cape Cod Hospital Hyannis Massachusetts
United States Clarion Health Partners Inc. Indianapolis Indiana
United States Community Hospitals of Indianapolis - Regional Cancer Center Indianapolis Indiana
United States University of Iowa Hospitals and Clinics Iowa City Iowa
United States Jackson-Madison County General Hospital Jackson Tennessee
United States CCOP - Kalamazoo Kalamazoo Michigan
United States CCOP - Kansas City Kansas City Missouri
United States CCOP - Dayton Kettering Ohio
United States Baptist Regional Cancer Center - Knoxville Knoxville Tennessee
United States Gundersen Lutheran Medical Foundation La Crosse Wisconsin
United States Wilford Hall - 59th Medical Wing Lackland Air Force Base Texas
United States Romagosa Radiation Oncology Center Lafayette Louisiana
United States CCOP - Southern Nevada Cancer Research Foundation Las Vegas Nevada
United States Norris Cotton Cancer Center Lebanon New Hampshire
United States Albert B. Chandler Medical Center, University of Kentucky Lexington Kentucky
United States Veterans Affairs Medical Center - Lexington Lexington Kentucky
United States Loma Linda University Medical Center Loma Linda California
United States Veterans Affairs Medical Center - Long Beach Long Beach California
United States Jonsson Comprehensive Cancer Center, UCLA Los Angeles California
United States Kaiser Permanente Medical Center - Los Angeles Los Angeles California
United States USC/Norris Comprehensive Cancer Center Los Angeles California
United States James Graham Brown Cancer Center Louisville Kentucky
United States Louisville Radiation Oncology Louisville Kentucky
United States Virginia Baptist Hospital Lynchburg Virginia
United States Southern Wisconsin Radiotherapy Center Madison Wisconsin
United States University of Wisconsin Comprehensive Cancer Center Madison Wisconsin
United States Veterans Affairs Medical Center - Madison Madison Wisconsin
United States Merle M. Mahr Cancer Center Madisonville Kentucky
United States Elliot Regional Cancer Center Manchester New Hampshire
United States CCOP - North Shore University Hospital Manhasset New York
United States Marquette General Hospital Marquette Michigan
United States Marshfield Clinic Marshfield Wisconsin
United States Veterans Affairs Outpatient Clinic - Martinez Martinez California
United States Loyola University Medical Center Maywood Illinois
United States Health First Holmes Regional Medical Center Melbourne Florida
United States CCOP - Baptist Cancer Institute Memphis Tennessee
United States University of Tennessee, Memphis Cancer Center Memphis Tennessee
United States Community Memorial Hospital Menomonee Falls Wisconsin
United States East Jefferson General Hospital Metairie Louisiana
United States Baptist Hospital of Miami Miami Florida
United States Sylvester Cancer Center, University of Miami Miami Florida
United States CCOP - Mount Sinai Medical Center Miami Beach Florida
United States South Jersey Hospital - Millville Millville New Jersey
United States Columbia Hospital Milwaukee Wisconsin
United States Medical College of Wisconsin Milwaukee Wisconsin
United States St. Joseph's Hospital Milwaukee Wisconsin
United States St. Luke's Medical Center Milwaukee Wisconsin
United States Veterans Affairs Medical Center - Milwaukee (Zablocki) Milwaukee Wisconsin
United States UNI-MED Medical Center Minot North Dakota
United States MBCCOP - University of South Alabama Mobile Alabama
United States Urology Associates - Mobile AL Mobile Alabama
United States Alabama Oncology, LLC Montgomery Alabama
United States Fox Chase Cancer Center at Virtua-Memorial Hospital Burlington County Mount Holly New Jersey
United States Ball Memorial Hospital Muncie Indiana
United States Vanderbilt Cancer Center Nashville Tennessee
United States CCOP - Ochsner New Orleans Louisiana
United States MBCCOP - LSU Medical Center New Orleans Louisiana
United States Kaplan Cancer Center New York New York
United States Memorial Sloan-Kettering Cancer Center New York New York
United States Whittingham Cancer Center Norwalk Connecticut
United States CCOP - Bay Area Tumor Institute Oakland California
United States CCOP - Missouri Valley Cancer Consortium Omaha Nebraska
United States Methodist Cancer Center - Omaha Omaha Nebraska
United States Florida Radiation Oncology Group Orange Park Florida
United States MD Anderson Cancer Center Orlando Orlando Florida
United States Western Baptist Hospital Paducah Kentucky
United States Gulf Coast Cancer Treatment Center Panama City Florida
United States Lutheran General Cancer Care Center Park Ridge Illinois
United States Bayshore Medical Center Pasadena Texas
United States West Florida Cancer Institute - Pensacola Pensacola Florida
United States Methodist Medical Center of Illinois Peoria Illinois
United States Albert Einstein Cancer Center Philadelphia Pennsylvania
United States Allegheny University Hospitals- Hahnemann Philadelphia Pennsylvania
United States Fox Chase Cancer Center Philadelphia Pennsylvania
United States Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia Pennsylvania
United States University of Pennsylvania Cancer Center Philadelphia Pennsylvania
United States Veterans Affairs Medical Center - Philadelphia Philadelphia Pennsylvania
United States University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania
United States Western Pennsylvania Hospital Pittsburgh Pennsylvania
United States Champlain Valley Physicians Hospital Medical Center Plattsburgh New York
United States Cancer Care Center Pomona California
United States CCOP - Columbia River Program Portland Oregon
United States Maine Medical Center Portland Maine
United States Naval Medical Center, Portsmouth Portsmouth Virginia
United States Vassar Brothers Hospital Poughkeepsie New York
United States Lifespan: The Miriam Hospital Providence Rhode Island
United States Roger Williams Medical Center/Brown University Providence Rhode Island
United States Southeastern Wisconsin Regional Cancer Center Racine Wisconsin
United States Reading Hospital and Medical Center Reading Pennsylvania
United States Mercy Medical Center - Redding Redding California
United States Massey Cancer Center Richmond Virginia
United States Genesee Hospital - Rochester Rochester New York
United States Mayo Clinic Cancer Center Rochester Minnesota
United States University of Rochester Cancer Center Rochester New York
United States InterCommunity Cancer Center at Rome Rome Georgia
United States Green Mountain Oncology Group Rutland Vermont
United States Radiation Oncology Center - Sacramento Sacramento California
United States St. Mary's Medical Center Saginaw Michigan
United States Dixie Regional Medical Center Saint George Utah
United States Mallinckrodt Institute of Radiology Saint Louis Missouri
United States St. Louis University Health Sciences Center Saint Louis Missouri
United States Veterans Affairs Medical Center - Saint Louis Saint Louis Missouri
United States CCOP - Metro-Minnesota Saint Louis Park Minnesota
United States Bayfront Medical Center Saint Petersburg Florida
United States LDS Hospital Salt Lake City Utah
United States UCSF Cancer Center and Cancer Research Institute San Francisco California
United States Santa Cruz Radiation Oncology Medical Group, Inc. Santa Cruz California
United States CCOP - Santa Rosa Memorial Hospital Santa Rosa California
United States Mercy Hospital Cancer Center - Scranton Scranton Pennsylvania
United States Swedish Hospital Tumor Institute Seattle Washington
United States Virginia Mason Medical Center Seattle Washington
United States Grand View Hospital Sellersville Pennsylvania
United States Memorial Hospital of South Bend South Bend Indiana
United States St. Joseph's Radiation Oncology Center South Bend Indiana
United States CCOP - Upstate Carolina Spartanburg South Carolina
United States Deaconess Medical Center Spokane Washington
United States Cancer Research for the Ozarks Springfield Missouri
United States CCOP - Central Illinois Springfield Illinois
United States CCOP - Ozarks Regional Springfield Missouri
United States Stanford University Stanford California
United States H. Lee Moffitt Cancer Center and Research Institute Tampa Florida
United States CCOP - Toledo Community Hospital Oncology Program Toledo Ohio
United States Community Medical Center Toms River New Jersey
United States David Grant Medical Center Travis Air Force Base California
United States St. Francis Medical Center Trenton New Jersey
United States Arizona Cancer Center Tucson Arizona
United States St. John Medical Center Tulsa Oklahoma
United States Radiation Oncology Associates of West Alabama Tuscallosa Alabama
United States CCOP - Carle Cancer Center Urbana Illinois
United States South Georgia Medical Center Valdosta Georgia
United States New York Medical College Valhalla New York
United States Radiation Oncology Center - Walnut Creek Walnut Creek California
United States Walter Reed Army Medical Center Washington District of Columbia
United States Schiffler Oncology Center Wheeling West Virginia
United States Veterans Affairs Medical Center - White River Junction White River Junction Vermont
United States Wilkes Barre General Hospital Wilkes-Barre Pennsylvania
United States CCOP - Christiana Care Health Services Wilmington Delaware
United States CCOP - Southeast Cancer Control Consortium Winston-Salem North Carolina
United States Comprehensive Cancer Center of Wake Forest University Baptist Medical Center Winston-Salem North Carolina
United States CCOP - MainLine Health Wynnewood Pennsylvania
United States Yakima Valley Memorial Hospital Yakima Washington
United States York Hospital York Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
Radiation Therapy Oncology Group National Cancer Institute (NCI)

Countries where clinical trial is conducted

United States,  Canada, 

References & Publications (4)

Garofalo MC, Winter K, Regine WF, et al.: Recursive partitioning analysis (RPA) of prognostic factors in six Radiation Therapy Oncology Group (RTOG) trials of chemoradiotherapy for unresectable pancreatic cancer. [Abstract] Int J Radiat Oncol Biol Phys 66 (3 Suppl 1): A-144, S80-1, 2006.

Konski AA, Winter K, Khor L, et al.: Over-expression of RIa subunit (RIas) of protein kinase A may be a marker for favorable pancreatic cancer: an analysis of patients treated on Radiation Therapy Oncology Group (RTOG) 98-12. [Abstract] American Society o

Rich T, Harris J, Abrams R, Erickson B, Doherty M, Paradelo J, Small W Jr, Safran H, Wanebo HJ. Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12. Am J Clin Oncol. 2004 Feb;27(1):51- — View Citation

Rich T, Harris J, Abrams R, et al.: A phase II study of external irradiation and weekly paclitaxel for non-metastatic, unresectable pancreatic cancer: a preliminary report of RTOG protocol 98-12. [Abstract] Int J Radiat Oncol Biol Phys 51(3 suppl 1): A-51

Outcome

Type Measure Description Time frame Safety issue
Primary To determine the one-year and median survival rates after PXRT To determine the one-year and median survival rates after paclitaxel and external beam radiation therapy (PXRT) No
Secondary To determine the response rate of PXRT in unresectable pancreatic cancer in a multi-center trial No
Secondary To evaluate the acute and late treatment morbidity of paclitaxel in a multi-institutional setting No
Secondary To correlate p53 status with treatment response to PXRT No
See also
  Status Clinical Trial Phase
Completed NCT05305001 - Germline Mutations Associated With Hereditary Pancreatic Cancer in Unselected Patients With Pancreatic Cancer in Mexico
Completed NCT02526017 - Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers Phase 1
Recruiting NCT05497531 - Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers N/A
Recruiting NCT04927780 - Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer Phase 3
Recruiting NCT06054984 - TCR-T Cells in the Treatment of Advanced Pancreatic Cancer Early Phase 1
Recruiting NCT05919537 - Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation Phase 1
Terminated NCT03140670 - Maintenance Rucaparib in BRCA1, BRCA2 or PALB2 Mutated Pancreatic Cancer That Has Not Progressed on Platinum-based Therapy Phase 2
Terminated NCT00529113 - Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer Phase 1
Recruiting NCT05168527 - The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients Phase 2
Active, not recruiting NCT04383210 - Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors Phase 2
Recruiting NCT05391126 - GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care N/A
Terminated NCT03300921 - A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer Phase 1
Completed NCT03153410 - Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas Early Phase 1
Recruiting NCT03175224 - APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors Phase 2
Recruiting NCT05679583 - Preoperative Stereotactic Body Radiation Therapy in Patients With Resectable Pancreatic Cancer Phase 2
Recruiting NCT04183478 - The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic Cancer Phase 2/Phase 3
Terminated NCT03600623 - Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer Early Phase 1
Recruiting NCT04584008 - Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics N/A
Recruiting NCT05351983 - Patient-derived Organoids Drug Screen in Pancreatic Cancer N/A
Completed NCT04290364 - Early Palliative Care in Pancreatic Cancer - a Quasi-experimental Study